Variable | 56-day benchmark | 84-day benchmark | ||
HR | 95% CI | HR | 95% CI | |
Age at diagnosis | 0.95 | 0.92 to 0.99 | 0.95 | 0.92 to 0.98 |
Sex | ||||
Female | 1.0 | Reference | 1.0 | Reference |
Male | 1.54 | 0.85 to 2.77 | 1.21 | 0.82 to 1.79 |
Complications | ||||
No | 1.0 | Reference | 1.0 | reference |
Yes | 0.14 | 0.05 to 0.41 | 0.49 | 0.31 to 0.76 |
ECOG performance status | ||||
0 | 1.0 | Reference | 1.0 | Reference |
1–2 | 0.59 | 0.17 to 2.04 | 1.06 | 0.52 to 2.16 |
Unknown | 1.74 | 0.90 to 3.39 | 1.13 | 0.69 to 1.85 |
CCI score | ||||
2–3 | 1.0 | Reference | ||
4–5 | 1.63 | 0.87 to 3.04 | ||
6–9 | 1.39 | 0.53 to 3.56 | ||
Chemotherapy type | ||||
Intravenous | 1.0 | Reference | 1.0 | Reference |
Oral | 5.12 | 1.81 to 14.46 | 1.71 | 0.85 to 3.47 |
Period of diagnosis | ||||
2012–2013 | 1.0 | Reference | 1.0 | Reference |
2013–2014 | 0.50 | 0.25 to 0.98 | 1.21 | 0.76 to 1.90 |
2014–2015 | 0.28 | 0.12 to 0.69 | 0.72 | 0.43 to 1.22 |
Surgeon volume | ||||
High | 1.0 | Reference | 1.0 | Reference |
Low | 1.66 | 0.91 to 3.03 | 1.19 | 0.80 to 1.76 |
Surgery type | ||||
Laparoscopy | 1.0 | Reference | 1.0 | Reference |
Laparotomy | 2.36 | 1.20 to 4.65 | 1.24 | 0.81 to 1.89 |
Chemotherapy centre | ||||
A | 1.0 | Reference | ||
B | 0.81 | 0.51 to 1.28 | ||
C | 1.57 | 0.89 to 2.79 |
Bold estimates are significantly different from the reference group.
CCI, Charlson Comorbidity Index; ECOG, Eastern Cooperative Oncology Group.